Rationale for the EUCAST clinical breakpoints

First Page		Document Content
Date: 2010-10-14 03:28:33 Pathogenic bacteria Piperazines Tuberculosis Antibiotics Rifampicin Antibiotic resistance Enterococcus Staphylococcus Streptococcus pneumoniae Bacteria Microbiology Gram-positive bacteria		Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Download Document from Source Website File Size: 176,16 KB Share Document on Facebook

	PDF Document DocID: 1xRXL - View Document
	PDF Document DocID: 1xQkg - View Document
	PDF Document DocID: 1xQ5g - View Document
	PDF Document DocID: 1xLM9 - View Document
	PDF Document DocID: 1xKA5 - View Document